HR0163LRB103 31459 MST 59200 r HR0163 LRB103 31459 MST 59200 r
HR0163 LRB103 31459 MST 59200 r
1 HOUSE RESOLUTION
2 WHEREAS, Respiratory Syncytial Virus disease (RSV) is a
3 highly transmissible, seasonal virus that can have severe and
4 unpredictable outcomes for infants, including hospitalization;
5 and
6 WHEREAS, Nearly all children will be infected with RSV by
7 age two, and most infants requiring hospitalization were
8 previously healthy and born at term; and
9 WHEREAS, RSV is the leading cause of hospitalization among
10 infants in the U.S.; and
11 WHEREAS, RSV is the most common cause of bronchiolitis
12 (inflammation of the small airways in the lung) and pneumonia
13 (infection of the lungs) in children younger than one year of
14 age in the U.S.; and
15 WHEREAS, The current RSV season has resulted in
16 significant morbidity and increased mortality; and
17 WHEREAS, In the U.S., RSV infections typically occur
18 during late fall, winter, and early spring, which means urgent
19 preparation is needed; and
HR0163 LRB103 31459 MST 59200 r
HR0163- 2 -LRB103 31459 MST 59200 r HR0163 - 2 - LRB103 31459 MST 59200 r
HR0163 - 2 - LRB103 31459 MST 59200 r
1 WHEREAS, Monoclonal antibodies show promise in
2 preventative protection against RSV; and
3 WHEREAS, RSV disproportionally affects infants with
4 Medicaid coverage, Native Americans, and Alaskan Natives; and
5 WHEREAS, The Vaccines For Children (VFC) program is a
6 federally-funded program that provides vaccines at no cost to
7 children who might not otherwise be vaccinated because of
8 inability to pay; and
9 WHEREAS, VFC coverage is critical to ensure equity and
10 access for all infants in order to have the greatest impact on
11 disease burden; therefore, be it
12 RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE
13 HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
14 we urge the Centers for Disease Control and Prevention to
15 include new RSV immunization technologies (including vaccines
16 and monoclonal antibodies), within the federal VFC program if
17 the Advisory Committee on Immunization Practices of the
18 Centers for Disease Control and Prevention issues
19 administrative recommendations that are subsequently approved
20 by the Director of the Centers for Disease Control and
21 Prevention; and be it further
HR0163 - 2 - LRB103 31459 MST 59200 r
HR0163- 3 -LRB103 31459 MST 59200 r HR0163 - 3 - LRB103 31459 MST 59200 r
HR0163 - 3 - LRB103 31459 MST 59200 r
1 RESOLVED, That suitable copies of this resolution be
2 delivered to Director of the Centers for Disease Control and
3 Prevention Rochelle Walensky, Administrator of the Centers for
4 Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure,
5 and Secretary of the Department of Health and Human Services
6 Xavier Becerra.
HR0163 - 3 - LRB103 31459 MST 59200 r